Endogenous gamma delta T-cell receptor ligands (gamma delta TCR ligands)

Endogenous gamma delta (γδ) T-cell receptor ligands are a diverse group of molecules that trigger the activation of γδ T-cells, a unique subset of lymphocytes bridging innate and adaptive immunity (Vantourout & Hayday, 2013, Nat Rev Immunol). Unlike αβ T-cells, which recognize peptide antigens presented by MHC molecules, γδ T-cells recognize a variety of non-peptide ligands, including phosphoantigens, butyrophilins, and MHC-like stress-induced proteins (Morita et al., 2007, Immunol Rev). In humans, the Vγ9Vδ2 T-cell subset is primarily activated by isopentenyl pyrophosphate (IPP), an intermediate in the mevalonate pathway that accumulates in tumor cells or infected cells. This activation is mediated by the butyrophilin family proteins, specifically BTN3A1 and BTN2A1, which act as essential molecular sensors for intracellular phosphoantigens (Rigau et al., 2020, Science). These ligands play a critical role in immunosurveillance, allowing γδ T-cells to identify and eliminate malignant or stressed cells. Therapeutically, these ligands and their associated pathways are targeted using bisphosphonates to induce endogenous ligand accumulation or through monoclonal antibodies like ICT01 that stabilize the activating conformation of butyrophilins (ImCheck Therapeutics, 2023).

Other names

PhosphoantigensButyrophilinsMHC class I-related chain A/BMICA/BIsopentenyl pyrophosphateIPPNon-peptide antigensBTN3A1BTN2A1Annexin A2EPCRHMBPP

Activation of gamma delta T-cells via the stabilization of butyrophilin complexes (BTN3A1/BTN2A1) or the accumulation of intracellular phosphoantigens (e.g., IPP) that trigger TCR signaling (Rigau et al., 2020, Science).